A novel recombinant pseudorabies virus expressing parvovirus VP2 gene: Immunogenicity and protective efficacy in swine

Virology Journal

Volumn 8, Issue , 2011, Pages

  Chen, Yang ^a   Guo, Wanzhu ^a   Xu, Zhiwen ^a   Yan, Qigui ^a   Luo, Yan ^a   Shi, Qian ^b   Chen, Dishi ^a   Zhu, Ling ^a   Wang, Xiaoyu ^a  

^a SICHUAN AGRICULTURAL UNIVERSITY   (China)

^b Center of Epizootic Prevention and Supervision of Sichuan   (China)

Author keywords

Immunogenicity; Porcine parvovirus; Protective Efficacy; Recombinant pseudorabies virus; VP2 gene

Indexed keywords

DNA VACCINE; PARVOVIRUS VACCINE; PARVOVIRUS VECTOR; PROTEIN VP2; PRV SA125/VP2 VACCINE; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS VACCINE; CAPSID PROTEIN; DRUG CARRIER; RECOMBINANT VACCINE; VIRUS ANTIBODY; VIRUS ANTIGEN; VP2 PROTEIN, PORCINE PARVOVIRUS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; FETUS; GENE EXPRESSION; GILT (SWINE); HOMOLOGOUS RECOMBINATION; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOFLUORESCENCE; IMMUNOGENICITY; NONHUMAN; PARVOVIRUS; PARVOVIRUS INFECTION; PIGLET; PLASMID; POLYMERASE CHAIN REACTION; PSEUDORABIES HERPETOVIRUS; SWINE; VIRUS LIKE AGENT; VIRUS PURIFICATION; VIRUS RECOMBINANT; VIRUS STRAIN; WESTERN BLOTTING; ANIMAL; ANIMAL DISEASE; BLOOD; GENE VECTOR; GENETICS; IMMUNOLOGY; METHODOLOGY; PATHOGENICITY; PORCINE PARVOVIRUS; SURVIVAL; SWINE DISEASE; VACCINATION; VIROLOGY;

MIRIDAE; PARVOVIRUS; PORCINE PARVOVIRUS; SUID HERPESVIRUS 1; SUIDAE;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CAPSID PROTEINS; DRUG CARRIERS; GENE EXPRESSION; GENETIC VECTORS; HERPESVIRUS 1, SUID; PARVOVIRIDAE INFECTIONS; PARVOVIRUS, PORCINE; SURVIVAL ANALYSIS; SWINE; SWINE DISEASES; VACCINATION; VACCINES, SYNTHETIC; VIRAL VACCINES;

EID: 79959236226     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-307     Document Type: Article

References (29)

1. Viral wasting syndrome of swine: experimental reproduction of postweaning multisystemic wasting syndrome in gnotobiotic swine by co infection with porcine circovirus 2 and porcine parvovirus. S Krakowka JA Ellis B Meehan S Kennedy F McNeilly G Allan, Vet Pathol 2000 37 3 254 63 10.1354/vp.37-3-254 10810990
2. Parvovirus infection in pigs with necrotic and vesicle-like lesions. JI Kresse WD Taylor WW Stewart KA Eernisse, Veterinary Microbiology 1985 10 6 525 531 10.1016/0378-1135(85)90061-6 3006323 (Pubitemid 16175825)
3. Experimental Reproduction of Severe Wasting Disease by Co-infection of Pigs with Porcine Circovirus and Porcine Parvovirus. GM Allan S Kennedy F McNeilly JC Foster JA Ellis SJ Krakowka BM Meehan BM Adair, Journal of Comparative Pathology 1999 121 1 1 11 10.1053/jcpa.1998.0295 10373289 (Pubitemid 29332697)
4. Effect of vaccinal and passive immunity on experimental infection of pigs with porcine parvovirus. PS Paul WL Mengeling TT Brown, Am J Vet Res 1980 41 9 1368 71 7447129
5. The effect of porcine parvovirus and porcine reproductive and respiratory syndrome virus on porcine reproductive performance. WL Mengeling KM Lager AC Vorwald, Anim Reprod Sci 2000 60-61 199 210 10.1016/S0378-4320(00)00135-4 10844195 (Pubitemid 30397793)
6. Efficacy of an inactivated virus vaccine for prevention of porcine parvovirus-induced reproductive failure. WL Mengeling TT Brown PS Paul DE Gutekunst, Am J Vet Res 1979 40 2 204 7 464358 (Pubitemid 10111366)
7. Production of porcine parvovirus empty capsids with high immunogenic activity. C Martinez K Dalsgaard JA Lopez de Turiso E Cortes C Vela JI Casal, Vaccine 1992 10 10 684 90 10.1016/0264-410X(92)90090-7 1523879
8. A recombinant pseudorabies virus expressing rabies virus glycoprotein: safety and immunogenicity in dogs. Z Yuan S Zhang Y Liu F Zhang AR Fooks Q Li R Hu, Vaccine 2008 26 10 1314 21 10.1016/j.vaccine.2007.12.050 18262313
9. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus. X Li R Liu H Tang M Jin H Chen P Qian, Vaccine 2008 26 22 2714 22 10.1016/j.vaccine.2008.03.020 18436351
10. Immunogenicity and protective efficacy of recombinant pseudorabies virus expressing the two major membrane-associated proteins of porcine reproductive and respiratory syndrome virus. Y Jiang L Fang S Xiao H Zhang Y Pan R Luo B Li H Chen, Vaccine 2007 25 3 547 60 10.1016/j.vaccine.2006.07.032 16920232 (Pubitemid 44856086)
11. The co-administrating of recombinant porcine IL-2 could enhance protective immune responses to PRV inactivated vaccine in pigs. Y Lin H Qigai Y Xiaolan B Weicheng C Huanchun, Vaccine 2005 23 35 4436 41 10.1016/j.vaccine. 2005.03.034 15946776 (Pubitemid 40991229)
12. Construction of recombinant pseudorabies virus expressing NS1 protein of Japanese encephalitis (SA14-14-2) virus and its safety and immunogenicity. G Xu X Xu Z Li Q He B Wu S Sun H Chen, Vaccine 2004 22 15-16 1846 53 10.1016/j.vaccine.2003.09.015 15121294 (Pubitemid 38581052)
13. Generation and immunogenicity of a recombinant pseudorabies virus expressing cap protein of porcine circovirus type 2. Y Song M Jin S Zhang X Xu S Xiao S Cao H Chen, Vet Microbiol 2007 119 2-4 97 104 10.1016/j.vetmic.2006.08. 026 17005335 (Pubitemid 46027451)
14. Assembly of pseudorabies virus genome-based transfer vehicle carrying major antigen sites of S gene of transmissible gastroenteritis virus: potential perspective for developing live vector vaccines. J Yin X Ren Z Tian Y Li, Biologicals 2007 35 1 55 61 10.1016/j.biologicals.2006.02.001 16731004 (Pubitemid 46282492)
15. Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine against both pseudorabies and hog cholera. M van Zijl G Wensvoort E de Kluyver M Hulst H van der Gulden A Gielkens A Berns R Moormann, J Virol 1991 65 5 2761 5 1850051
16. Complete, annotated sequence of the pseudorabies virus genome. BG Klupp CJ Hengartner TC Mettenleiter LW Enquist, J Virol 2004 78 1 424 40 10.1128/JVI.78.1.424-440.2004 14671123 (Pubitemid 37549753)
17. Role of pseudorabies virus Us3 protein kinase during neuronal infection. LM Olsen TH Ch'ng JP Card LW Enquist, J Virol 2006 80 13 6387 98 10.1128/JVI.00352-06 16775327 (Pubitemid 43927442)
18. Contribution of single genes within the unique short region of Aujeszky's disease virus (suid herpesvirus type 1) to virulence, pathogenesis and immunogenicity. TG Kimman N de Wind N Oei-Lie JM Pol AJ Berns AL Gielkens, J Gen Virol 1992 73 Pt 2 243 51 1311354
19. The Biological Characteristics of a Gene-deleted Pseudorabies Virus Vaccine Strain (SA215). L Chen W Guo Z Xu X Wang Y Wang, Chinese Journal of Animal and Veterinary Sciences 2005 36 3 278 282 (Pubitemid 40677845)
20. Construction of new generation Pseudorabies virus gene deleted vaccine and the study of biologic characteristics. W Guo Z Xu X Wang L Chen Y Wang M Wang, Journal of Sichuan Agricultural University 2000 18 1 1 10
21. Use of parvovirus-like particles for vaccination and induction of multiple immune responses. JI Casal P Rueda A Hurtado, Biotechnol Appl Biochem 1999 29 Pt 2 141 50 10075910 (Pubitemid 29178913)
22. Production and purification of VP2 protein of porcine parvovirus expressed in an insect-baculovirus cell system. H Zhou G Yao S Cui, Virol J 2010 7 366 10.1186/1743-422X-7-366 21143963
23. Parvovirus diagnostics and vaccine production in insect cells. JI Casal, Cytotechnology 1996 20 1 261 270 10.1007/BF00350405 (Pubitemid 26350943)
24. A novel recombinant virus-like particle vaccine for prevention of porcine parvovirus-induced reproductive failure. AFG Antonis CJM Bruschke P Rueda L Maranga JI Casal C Vela AT Hilgers Luuk BGM Belt Peter K Weerdmeester JT Carrondo Manuel PM Langeveld Jan, Vaccine 2006 24 26 5481 5490 10.1016/j.vaccine.2006.03.089 16730104 (Pubitemid 43831379)
25. Scale-up of virus-like particles production: effects of sparging, agitation and bioreactor scale on cell growth, infection kinetics and productivity. L Maranga A Cunha J Clemente P Cruz MJ Carrondo, J Biotechnol 2004 107 1 55 64 10.1016/j.jbiotec.2003.09.012 14687971 (Pubitemid 38010269)
26. Parvovirus-Like Particles as Vaccine Vectors. JI Casal P Rueda A Hurtado, Methods 1999 19 1 174 186 10.1006/meth.1999.0843 10525454 (Pubitemid 29497768)
27. Recombinant parvovirus-like particles as an antigen carrier: a novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells. C Sedlik M Saron J Sarraseca JI Casal C Leclerc, Proc Natl Acad Sci USA 1997 94 14 7503 8 10.1073/pnas.94.14.7503 9207121 (Pubitemid 27345345)
28. Development of recombinant porcine parvovirus-like particles as an antigen carrier formed by the hybrid VP2 protein carrying immunoreactive epitope of porcine circovirus type 2. Q Pan K He K Huang, Vaccine 2008 26 17 2119 2126 18378364
29. Aujeszky's disease virus: opportunities and challenges. FA Zuckermann, Vet Res 2000 31 1 121 31 10726641